Brenntag AG (DE:BNR)
XETRA:BNR
Want to see DE:BNR full AI Analyst Report?
Top Page
Brenntag AG
(XETRA:BNR)
Select Model
Select Model
Rating:54Neutral
Price Target:
€63.00
▲(6.28% Upside)
Action:ReiteratedDate:03/14/26
The score is primarily constrained by weakening financial performance (multi-year revenue decline and margin/net income compression) despite a still-manageable balance sheet and positive cash generation. Technical indicators add caution due to below-average price trends and negative momentum. Valuation is balanced by a strong dividend yield but offset by a relatively high P/E given the recent earnings softness.
Positive Factors
Broad distribution & value-added services
Brenntag’s core distribution model and value-added services (blending, repackaging, technical support, warehousing) create durable customer stickiness and diversification across end markets. This structure supports repeat volumes, higher-margin specialty sales and competitive barriers to entry over months.
Negative Factors
Multi-year revenue decline
A multi-year top-line decline reduces scale advantages in procurement and logistics, weakening bargaining power with suppliers and customers. Continued revenue contraction pressures utilization of distribution assets and may permanently lower long-term margin potential absent structural demand recovery.
Read all positive and negative factors
Positive Factors
Negative Factors
Broad distribution & value-added services
Brenntag’s core distribution model and value-added services (blending, repackaging, technical support, warehousing) create durable customer stickiness and diversification across end markets. This structure supports repeat volumes, higher-margin specialty sales and competitive barriers to entry over months.
Read all positive factors
Brenntag AG (BNR) vs. iShares MSCI Germany ETF (EWG)
Market Cap
€8.94B
Dividend Yield4.3%
Average Volume (3M)359.07K
Price to Earnings (P/E)―
Beta (1Y)0.94
Revenue Growth-6.56%
EPS Growth-50.65%
CountryDE
Employees18,122
SectorGeneral
Sector StrengthN/A
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)1.83
Shares Outstanding144,385,380
10 Day Avg. Volume336,769
30 Day Avg. Volume359,071
Financial Highlights & Ratios
PEG Ratio-0.53
Price to Book (P/B)1.66
Price to Sales (P/S)0.47
P/FCF Ratio10.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€55.86Price Target Upside-5.77% Downside
Rating ConsensusHold
Number of Analyst Covering9
EPS Forecast (FY)3.68
Revenue Forecast (FY)€15.04B
Brenntag AG Business Overview & Revenue Model
Company Description
Brenntag SE purchases and supplies various industrial and specialty chemicals, and ingredients in Europe, the Middle East, Africa, North America, Latin America, the Asia Pacific, and internationally. The company operates through the divisions Bren...
How the Company Makes Money
Brenntag primarily makes money by distributing chemicals and ingredients on behalf of manufacturers and selling them to industrial and specialty customers at a margin. Its core revenue model is based on (1) product sales: purchasing chemicals from...
Brenntag AG Financial Statement Overview
Summary
Income Statement
52
Neutral
Balance Sheet
63
Positive
Cash Flow
58
Neutral
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 15.17B | 16.24B | 16.82B | 19.43B | 14.38B |
| Gross Profit | 1.96B | 4.03B | 4.02B | 4.32B | 3.38B |
| EBITDA | 1.16B | 1.33B | 1.51B | 1.70B | 1.03B |
| Net Income | 264.60M | 536.20M | 714.90M | 886.80M | 448.30M |
Balance Sheet | |||||
| Total Assets | 10.84B | 11.67B | 10.34B | 11.37B | 10.20B |
| Cash, Cash Equivalents and Short-Term Investments | 797.90M | 763.30M | 576.90M | 1.05B | 705.00M |
| Total Debt | 3.26B | 3.38B | 2.40B | 2.93B | 2.66B |
| Total Liabilities | 6.49B | 6.91B | 5.98B | 6.57B | 6.20B |
| Stockholders Equity | 4.31B | 4.73B | 4.30B | 4.75B | 3.91B |
Cash Flow | |||||
| Free Cash Flow | 673.70M | 564.40M | 1.34B | 689.50M | 189.30M |
| Operating Cash Flow | 966.70M | 906.60M | 1.66B | 956.70M | 388.60M |
| Investing Cash Flow | -410.20M | -749.00M | -558.30M | -401.40M | -608.50M |
| Financing Cash Flow | -489.10M | 23.00M | -1.55B | -225.80M | 174.10M |
Brenntag AG Technical Analysis
Positive
59.28
Price Trends
53.73
Positive
51.79
Positive
51.90
Positive
Market Momentum
1.99
Negative
63.28
Neutral
72.87
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:BNR, the sentiment is Positive. The current price of 59.28 is above the 20-day moving average (MA) of 56.24, above the 50-day MA of 53.73, and above the 200-day MA of 51.90, indicating a bullish trend. The MACD of 1.99 indicates Negative momentum. The RSI at 63.28 is Neutral, neither overbought nor oversold. The STOCH value of 72.87 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DE:BNR.
Brenntag AG Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | €8.14B | 86.47 | 3.10% | 8.92% | -7.17% | 19.37% | |
58 Neutral | €10.61B | -124.46 | 9.75% | 1.75% | -1.39% | -47.86% | |
57 Neutral | €4.66B | 100.12 | -18.97% | 3.75% | ― | ― | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
54 Neutral | €8.94B | -69.34 | 6.03% | 4.30% | -6.56% | -50.65% | |
53 Neutral | €1.56B | -0.96 | -14.66% | 0.59% | -10.89% | -225.99% | |
45 Neutral | €12.42B | -7.53 | -10.04% | ― | -8.72% | -140.66% |
* General Sector Average
DE:BNR
Brenntag AG
61.90
4.57
7.97%
DE:1COV
Covestro
59.80
0.26
0.44%
DE:EVK
Evonik
17.47
-1.36
-7.23%
DE:SY1
Symrise
75.90
-25.82
-25.39%
DE:LXS
LANXESS
18.06
-8.58
-32.20%
DE:WCH
Wacker Chemie AG
93.90
28.20
42.92%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.